Literature DB >> 3284817

Macrophage activity in resistant and susceptible mouse strains infected with Mycobacterium lepraemurium.

S J Brett1, R Butler.   

Abstract

The level of activation of peritoneal macrophages following subcutaneous inoculation of resistant (C57BL) and susceptible (BALB/c) mice was assessed by monitoring superoxide anion and hydrogen peroxide production and also tumour cell cytostasis. The level of systemic macrophage activation appeared to correlate with bacterial load, rather than resistance to infection. It was observed that the more susceptible (BALB/c) strain developed higher and more sustained levels of systemic macrophage activation, whereas the more resistant (C57BL) strain showed only low transient levels of macrophage activation. In contrast, in vivo challenge of subcutaneously infected C57BL mice, via the intra-peritoneal route, with heat-killed Mycobacterium lepraemurium and thioglycollate resulted in a high level of macrophage activation compared with similarly treated uninfected mice. Similar treatment of susceptible BALB/c mice, however, did not result in enhanced macrophage activation. It was also observed that high levels of macrophage activation occurred in T-cell deprived C57BL mice following infection with M. lepraemurium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284817      PMCID: PMC1454777     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line.

Authors:  P Scott; S James; A Sher
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

Review 2.  Mechanisms of macrophage antimicrobial activity.

Authors:  C F Nathan
Journal:  Trans R Soc Trop Med Hyg       Date:  1983       Impact factor: 2.184

Review 3.  The role of cell-mediated immunity in bacterial infections.

Authors:  H Hahn; S H Kaufmann
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

4.  The susceptibility of strains of Mycobacterium tuberculosis to catalase-mediated peroxidative killing.

Authors:  P S Jackett; V R Aber; D B Lowrie
Journal:  J Gen Microbiol       Date:  1980-12

5.  H-2 linkage control of resistance to subcutaneous infection with Mycobacterium lepraemurium.

Authors:  J Curtis; H O Adu; J L Turk
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

6.  Macrophages and protective immunity in Mycobacterium lepraemurium infections in a 'resistant' (C57Bl) and a 'susceptible' (BALB/c) mouse strain.

Authors:  P M Preston
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

7.  Superoxide release by peritoneal and bone marrow-derived mouse macrophages. Modulation by adherence and cell activation.

Authors:  G Berton; S Gordon
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

8.  Macrophage activity in Mycobacterium leprae infection.

Authors:  A K Sharp; D K Banerjee
Journal:  Acta Leprol       Date:  1984 Oct-Dec

9.  Listeria monocytogenes-reactive T lymphocyte clones with cytolytic activity against infected target cells.

Authors:  S H Kaufmann; E Hug; G De Libero
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  STUDIES ON THE RECOVERY OF THE IMMUNE RESPONSE IN IRRADIATED MICE THYMECTOMIZED IN ADULT LIFE.

Authors:  A M CROSS; E LEUCHARS; J F MILLER
Journal:  J Exp Med       Date:  1964-05-01       Impact factor: 14.307

View more
  3 in total

1.  Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Authors:  Hong Xin; Jim E Cutler
Journal:  Clin Vaccine Immunol       Date:  2011-08-10

2.  Antigen presentation by macrophages from bacille Calmette-Guérin (BCG)-resistant and -susceptible mice.

Authors:  M E Hilburger; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

3.  Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium.

Authors:  A Sarmento; R Appelberg
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.